Non-adherence to drug therapy and drug acquisition costs in a national population - a patient-based register study

Table 3 Drug acquisition costs related to non-adherence with different number of dispensed drugs in Sweden 2006.

			DDD		Acq cost		PNA	Prescribed	SNA	Cost related	non-adherence
Therapy	Age	DP	million	%	million	%	rate	drug cost	rate	million	%
Conti.	0-19	DP1-4	106	2	329	1, 4	3	339	40	126	38, 1
		DP5-9	56	1, 1	224	1	2	229	50	110	49, 0
		DP10-14	13	0, 2	61	0, 3	2	63	50	30	49, 0
		DP15-	4	0, 1	36	0, 2	2	37	60	21	59, 2
	20-49	DP1-4	273	5, 2	1151	5	4	1199	40	432	37, 5
		DP5-9	236	4, 5	1301	5, 6	4	1356	50	624	47, 9
		DP10-14	106	2	610	2, 6	4	636	50	292	47, 9
		DP15-	81	1, 5	479	2, 1	4	499	60	279	58, 3
	50-69	DP1-4	250	4, 8	855	3, 7	3	882	40	326	38, 1
		DP5-9	532	10, 1	1820	7, 9	3	1876	50	882	48, 5
		DP10-14	338	6, 4	1286	5, 6	3	1326	50	623	48, 5
		DP15-	288	5, 5	1305	5, 6	3	1346	60	767	58, 8
	70-	DP1-4	118	2, 3	328	1, 4	2	335	40	127	38, 8
		DP5-9	516	9, 8	1276	5, 5	2	1302	50	625	49, 0
		DP10-14	525	10	1337	5, 8	2	1364	50	655	49, 0
		DP15-	485	9, 2	1398	6	2	1426	60	827	59, 2
Short-	0-19	DP1-4	36	0, 7	550	2, 3	2	560	20	101	18, 3
term		DP5-9	20	0, 4	263	1, 1	2	268	30	75	28, 5
		DP10-14	5	0, 1	87	0, 4	2	88	40	33	38, 4
		DP15-	2	0	38	0, 2	2	39	50	19	49, 3
	20-49	DP1-4	97	1, 8	796	3, 4	4	830	20	133	16, 7
		DP5-9	98	1, 8	764	3, 3	4	795	30	207	27, 1
		DP10-14	46	0, 9	363	1, 5	4	379	40	136	37, 6
		DP15-	39	0, 7	310	1, 3	4	323	50	149	47, 9
	50-69	DP1-4	94	1, 8	562	2, 5	3	579	20	98	17, 5
		DP5-9	169	3, 2	1000	4, 3	3	1031	30	278	27, 8
		DP10-14	113	2, 2	692	2, 9	3	714	40	264	38, 2
		DP15-	111	2, 2	734	3, 2	3	756	50	355	48, 4
	70-	DP1-4	39	0, 7	191	0, 8	2	196	20	35	18, 5
		DP5-9	142	2, 8	679	2, 9	2	693	30	194	28, 6
		DP10-14	155	3	763	3, 3	2	778	40	296	38, 7
		DP15-	161	3	868	3, 8	2	886	50	425	49, 0
No DDD			0	0	697	3		718	50	309	44, 3
All			5254	100	23153	99, 9		23848		9855	42, 6

DDD, acquisition costs for dispensed drugs (Acq cost), rate of primary non-adherence (PNA), estimated acquisition costs for prescribed drugs, rate of secondary non-adherence (SNA)and drug acquisition costs related to non-adherence for individuals with varying therapies, age and different number of dispensed drugs in Sweden in 2006

ISSN: 1472-6963